BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7433273)

  • 1. [Various parameters of cellular mass metabolism in highly differentiated thyroid cancer].
    Sznapka Z
    Pol Przegl Chir; 1980 Aug; 52(8):665-8. PubMed ID: 7433273
    [No Abstract]   [Full Text] [Related]  

  • 2. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
    Shaha AR
    Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of distant iodine-negative metastases of thyroid cancer with 32P].
    Drozdovskiĭ BI; Proshin VV
    Vopr Onkol; 1996; 42(3):71-2. PubMed ID: 8801747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surgical therapy of differentiated thyroid gland carcinoma].
    Walgenbach S; Sternheim E; Bittinger F; Junginger T
    Zentralbl Chir; 1997; 122(4):252-8. PubMed ID: 9221635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of estrogen receptor, progesterone receptor, and vascular endothelial growth factor-A in thyroid cancer.
    Kansakar E; Chang YJ; Mehrabi M; Mittal V
    Am Surg; 2009 Sep; 75(9):785-9; discussion 789. PubMed ID: 19774949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA is elevated in advanced stages of thyroid carcinoma.
    Shi Y; Parhar RS; Zou M; Hammami MM; Akhtar M; Lum ZP; Farid NR; Al-Sedairy ST; Paterson MC
    Br J Cancer; 1999 Mar; 79(7-8):1234-9. PubMed ID: 10098765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the relationship between age and thyroid cancer.
    Haymart MR
    Oncologist; 2009 Mar; 14(3):216-21. PubMed ID: 19270027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma.
    Wiseman SM; Masoudi H; Niblock P; Turbin D; Rajput A; Hay J; Filipenko D; Huntsman D; Gilks B
    Am J Surg; 2006 May; 191(5):581-7. PubMed ID: 16647341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic domain of proEGF affects distribution and post-translational modification of microtubuli and increases microtubule-associated proteins 1b and 2 production in human thyroid carcinoma cells.
    Pyka J; Glogowska A; Dralle H; Hoang-Vu C; Klonisch T
    Cancer Res; 2005 Feb; 65(4):1343-51. PubMed ID: 15735020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nodular goiter and thyroid cancer].
    Valdina EA
    Vestn Khir Im I I Grek; 1997; 156(2):23-6. PubMed ID: 9235760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors influencing survival after surgical treatment of well differentiated thyroid cancer].
    Nowak W; Szybiński P; Nowak K; Stachura J; Popiela T
    Wiad Lek; 2004; 57(9-10):431-7. PubMed ID: 15765757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
    Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
    Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Galectin-3 in diagnosis of thyroid cancer].
    Semenov DIu; Pozharisskiĭ KM; Boriskova ME; Pankova PA; Mukhina MS; Feshchenko NS
    Vopr Onkol; 2008; 54(3):321-3. PubMed ID: 18652236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical strategies in the diagnosis and treatment of patients with differentiated thyroid cancer].
    Lipskaia EV; Romanchishen AF; Kolosiuk VA
    Vestn Khir Im I I Grek; 2004; 163(1):11-5. PubMed ID: 15143574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medullary thyroid carcinoma: prognostic factors.
    Riddell DA; Lampe HB; Cramer H; Troster M
    J Otolaryngol; 1993 Jun; 22(3):180-3. PubMed ID: 7690409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radical surgical treatment of differentiated thyroid cancer--necessity or over-enthusiasm?].
    Nowak W; Szybiński P
    Wiad Lek; 2001; 54 Suppl 1():189-97. PubMed ID: 12182024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
    Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
    Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer.
    Cheng S; Liu W; Mercado M; Ezzat S; Asa SL
    Endocr Relat Cancer; 2009 Jun; 16(2):455-66. PubMed ID: 19261683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reciprocal immunohistochemical expression of sodium/iodide symporter and hexokinase I in primary thyroid tumors with synchronous cervical metastasis.
    Jung YH; Hah JH; Sung MW; Kim KH; Cho SY; Jeon YK
    Laryngoscope; 2009 Mar; 119(3):541-8. PubMed ID: 19235753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.